Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Journal of Clinical Investigation|May 1, 2025
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patientsRamon Staeger, Aizhan Tastanova, Adhideb Ghosh, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Elife|January 13, 2021
MITF reprograms the extracellular matrix and focal adhesion in melanomaRamile Dilshat, Valerie Fock, Colin Kenny, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumorsFlorentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
Cancer Research|March 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M Eichhoff, Corinne I Stoffel, Jan Käsler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 TherapyNina Zila, Ossia M Eichhoff, Irene Steiner, et al.
Nature Communications|March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doublingIsmael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Pageof 7